Sākums › Sirds mazspēja › Teksasa › Dallas
Sirds mazspēja klīniskie pētījumi Dallas, TX
42 pētījumi par Sirds mazspēja meklē dalībniekus vietās Dallas apkaimē (aptuveni 30 jūdžu rādiusā). Atveriet pētījumu, lai redzētu, kas var piedalīties un kā sazināties ar pētījuma komandu.
Oficiālais pētījuma teksts (angļu valodā)
Meklējat dalībniekus pētījumam? Izceliet to šīs lapas augšdaļā — $99 par 30 dienām →
ELEVATE-HFpEF Clinical Study
Notiek dalībnieku piesaiste
- Dallas VA Medical Center, Dallas
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Notiek dalībnieku piesaiste3. fāze
- Research Site, Dallas
- Research Site, Dallas
- Research Site, Dallas
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Notiek dalībnieku piesaiste3. fāze
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Notiek dalībnieku piesaiste3. fāze
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Notiek dalībnieku piesaiste2. fāze
- University of Texas Southwestern Medical Center, Dallas
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Notiek dalībnieku piesaiste
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Notiek dalībnieku piesaiste3. fāze
- Research Site, Dallas
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Notiek dalībnieku piesaiste3. fāze
- Baylor University Medical Center, Dallas
- The University of Texas Southwestern Medical Center, Dallas
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Notiek dalībnieku piesaiste
- University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location, Dallas
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Notiek dalībnieku piesaiste3. fāze
- Cedar Health Research, LLC, Dallas
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Notiek dalībnieku piesaiste3. fāze
- Research Site, Dallas
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Notiek dalībnieku piesaiste3. fāze
- Dallas, TX Investigative Site 10042, Dallas
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Notiek dalībnieku piesaiste
- Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
- UT southwestern Medical Center, Dallas
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Notiek dalībnieku piesaiste2. fāze
- Local Institution - 167, Dallas
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Notiek dalībnieku piesaiste2/3. fāze
- Children's Health-The Heart Center ( Site 0015), Dallas
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Notiek dalībnieku piesaiste2. fāze
- University of Texas Southwestern Medical Center, Dallas, Dallas
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Notiek dalībnieku piesaisteNovērojumu pētījums
- Dallas, Dallas
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Notiek dalībnieku piesaisteNovērojumu pētījums
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Notiek dalībnieku piesaiste3. fāze
- Tenax Investigational Site, Dallas
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Notiek dalībnieku piesaiste3. fāze
- Renal Disease Research Institute, Dallas
- Texas Health Heart and Vascular Specialists, Dallas
- Southwest Family Medicine_Dallas, Dallas
- un vēl 1
Alleviant ALLAY-HF Study
Notiek dalībnieku piesaiste
- UT Southwestern, Dallas
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Notiek dalībnieku piesaiste
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Notiek dalībnieku piesaisteNovērojumu pētījums
- Baylor University Medical Center, Dallas
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Notiek dalībnieku piesaiste2. fāze
- Children's Health Dallas, Dallas
Assessment of CCM in HF With Higher Ejection Fraction
Notiek dalībnieku piesaiste
- Baylor Scott and White Research Institute, Dallas
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Notiek dalībnieku piesaiste3. fāze
- Children's Medical Center Dallas - Cardiology, Dallas
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Notiek dalībnieku piesaiste
- Medical City Healthcare Dallas, Dallas
- Baylor Scott & White -Dallas, Dallas
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Notiek dalībnieku piesaiste3. fāze
- Children's Medical Center Dallas - Cardiology, Dallas
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Notiek dalībnieku piesaiste
- Baylor University Hospital, Dallas
Home-based Cardiac Rehabilitation in Heart Failure
Notiek dalībnieku piesaiste3. fāze
- University of Texas Southwestern Medical Center, Dallas
- Baylor Scott and White Health System, Dallas
IEEM-Heat and Heart Failure
Notiek dalībnieku piesaisteGaidīti veseli brīvprātīgie
- Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas, Dallas
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Notiek dalībnieku piesaiste
- UT Southwestern Medical Center, Dallas
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Notiek dalībnieku piesaiste3. fāze
- University of Texas Southwestern, Dallas
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Notiek dalībnieku piesaiste
- University of Texas Southwestern Medical Center, Dallas
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
Notiek dalībnieku piesaiste2. fāze
- UT Southwestern Medical Center, Dallas
Cardiopulmonary Stress Testing (CPET) AlloSure Study
Notiek dalībnieku piesaisteNovērojumu pētījums
- Baylor Scott & White health research institute, Dallas
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
Notiek dalībnieku piesaiste2. fāze
- Baylor University Medical Center, Dallas
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Notiek dalībnieku piesaiste2/3. fāze
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Cardiogenic Shock Working Group Registry
Notiek dalībnieku piesaisteNovērojumu pētījums
- Baylor Scott & White Advanced Heart Failure Clinic, Dallas
Get With The Guidelines-Heart Failure Registry
Notiek dalībnieku piesaisteNovērojumu pētījumsGaidīti veseli brīvprātīgie
- Amy Bennett, Dallas
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Notiek dalībnieku piesaisteNovērojumu pētījums
- UT Southwestern Medical Center, Dallas
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Notiek dalībnieku piesaiste1/2. fāze
- University of Texas Southwestern Medical Center, Dallas
Sirds mazspēja pētījumi citās pilsētās
- New York City, NY51 pētījums
- Boston, MA44 pētījumi
- Houston, TX36 pētījumi
- Cleveland, OH33 pētījumi
- Chicago, IL31 pētījums
- Philadelphia, PA31 pētījums
- San Francisco, CA29 pētījumi
- St. Louis, MO26 pētījumi
- Durham, NC26 pētījumi
- Kansas City, MO25 pētījumi
- Atlanta, GA25 pētījumi
- Baltimore, MD24 pētījumi
Citi pētījumi Dallas
- Krūts vēzis55 pētījumi
- Mazšūnu plaušu vēzis52 pētījumi
- Metastātisks vēzis42 pētījumi
- Vēzis (visi veidi)37 pētījumi
- Priekšdziedzera vēzis36 pētījumi
- Kolorektālais vēzis33 pētījumi
- Aptaukošanās30 pētījumi
- Olnīcu vēzis28 pētījumi
- Urīnpūšļa vēzis27 pētījumi
- Plaušu vēzis27 pētījumi
- Endometrija vēzis24 pētījumi
- Sirds un asinsvadu slimības23 pētījumi
No ClinicalTrials.gov, dati iegūti 2026. gada 5. okt.. Katram pētījumam ir savi dalības nosacījumi; pētījuma komanda nosaka, kas var piedalīties.